Skip to main content
Top
Published in: Clinical Rheumatology 4/2016

01-04-2016 | Original Article

Impact of the polymorphism in vitamin D receptor gene BsmI and the risk of systemic lupus erythematosus: an updated meta-analysis

Authors: Weiping Hu, Guodong Niu, Yong Lin, Xiaoqing Chen, Ling Lin

Published in: Clinical Rheumatology | Issue 4/2016

Login to get access

Abstract

The etiology of system lupus erythematosus (SLE) still remains unclear, and vitamin D is associated with immune response. Although a few studies are conducted to investigate the association between polymorphism in vitamin D receptor (VDR) genes and SLE risk, their results are conflicting. Following the guideline of PRISMA, we conducted a systematic search and meta-analysis of the BsmI polymorphism rs1544410 and the risk of SLE. The pooled odds ratios (OR) and its 95 % confidential interval (CI) were calculated by using Stata Version 10 with dominant and recessive model and allele analyses. Nine studies were included in our meta-analysis with a total of 1247 SLE cases and 1687 controls. No significant association was found in both models in the overall population. Only Bb + BB genotypes showed a significantly elevated SLE risk in Asian subgroup with an OR of 3.26 (95 % CI = 1.30–8.17) while no significance was observed in Caucasian population. Notably, B allele significantly increased the SLE risk among Asian population with an OR of 2.29 (95 % CI = 1.14–4.61). No positive findings were reported in Caucasian population and in the overall analysis. In Asian population, Bb + BB genotype and B allele can significantly increase the SLE risk.
Literature
2.
go back to reference Lisnevskaia L, Murphy G, Isenberg D (2014) Systemic lupus erythematosus. Lancet 384(9957):1878–1888CrossRefPubMed Lisnevskaia L, Murphy G, Isenberg D (2014) Systemic lupus erythematosus. Lancet 384(9957):1878–1888CrossRefPubMed
3.
go back to reference D’Cruz DP, Khamashta MA, Hughes GR (2007) Systemic lupus erythematosus. Lancet 369(9561):587–596CrossRefPubMed D’Cruz DP, Khamashta MA, Hughes GR (2007) Systemic lupus erythematosus. Lancet 369(9561):587–596CrossRefPubMed
4.
go back to reference Zandman-Goddard G, Solomon M, Rosman Z et al (2012) Environment and lupus-related diseases. Lupus 21(3):241–250CrossRefPubMed Zandman-Goddard G, Solomon M, Rosman Z et al (2012) Environment and lupus-related diseases. Lupus 21(3):241–250CrossRefPubMed
5.
go back to reference Harley JB, Kelly JA, Kaufman KM (2006) Unraveling the genetics of systemic lupus erythematosus. Springer Semin Immunopathol 28(2):119–130CrossRefPubMed Harley JB, Kelly JA, Kaufman KM (2006) Unraveling the genetics of systemic lupus erythematosus. Springer Semin Immunopathol 28(2):119–130CrossRefPubMed
6.
go back to reference Bogdanos DP, Smyk DS, Rigopoulou EI et al (2012) Twin studies in autoimmune disease: genetics, gender and environment. J Autoimmun 38(2–3):J156–J169CrossRefPubMed Bogdanos DP, Smyk DS, Rigopoulou EI et al (2012) Twin studies in autoimmune disease: genetics, gender and environment. J Autoimmun 38(2–3):J156–J169CrossRefPubMed
7.
go back to reference Hristova M, Dourmishev L, Kamenarska Z et al (2013) Role of the promoter polymorphism IL-6 -174G/C in dermatomyositis and systemic lupus erythematosus. Biomed Res Int 2013:315365CrossRefPubMedPubMedCentral Hristova M, Dourmishev L, Kamenarska Z et al (2013) Role of the promoter polymorphism IL-6 -174G/C in dermatomyositis and systemic lupus erythematosus. Biomed Res Int 2013:315365CrossRefPubMedPubMedCentral
8.
9.
go back to reference Warchoł T, Mostowska A, Lianeri M et al (2012) XRCC1 Arg399Gln gene polymorphism and the risk of systemic lupus erythematosus in the Polish population. DNA Cell Biol 31(1):50–56CrossRefPubMedPubMedCentral Warchoł T, Mostowska A, Lianeri M et al (2012) XRCC1 Arg399Gln gene polymorphism and the risk of systemic lupus erythematosus in the Polish population. DNA Cell Biol 31(1):50–56CrossRefPubMedPubMedCentral
10.
go back to reference Hawn TR, Wu H, Grossman JM et al (2005) A stop codon polymorphism of Toll-like receptor 5 is associated with resistance to systemic lupus erythematosus. Proc Natl Acad Sci U S A 102(30):10593–10597CrossRefPubMedPubMedCentral Hawn TR, Wu H, Grossman JM et al (2005) A stop codon polymorphism of Toll-like receptor 5 is associated with resistance to systemic lupus erythematosus. Proc Natl Acad Sci U S A 102(30):10593–10597CrossRefPubMedPubMedCentral
11.
go back to reference Takahashi R, Tsutsumi A, Ohtani K et al (2005) Association of mannose binding lectin (MBL) gene polymorphism and serum MBL concentration with characteristics and progression of systemic lupus erythematosus. Ann Rheum Dis 64(2):311–314CrossRefPubMedPubMedCentral Takahashi R, Tsutsumi A, Ohtani K et al (2005) Association of mannose binding lectin (MBL) gene polymorphism and serum MBL concentration with characteristics and progression of systemic lupus erythematosus. Ann Rheum Dis 64(2):311–314CrossRefPubMedPubMedCentral
12.
go back to reference Moher D, Liberati A, Tetzlaff J et al (2010) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg 8(5):336–341CrossRefPubMed Moher D, Liberati A, Tetzlaff J et al (2010) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg 8(5):336–341CrossRefPubMed
13.
go back to reference Ozaki Y, Nomura S, Nagahama M et al (2000) Vitamin-D receptor genotype and renal disorder in Japanese patients with systemic lupus erythematosus. Nephron 85(1):86–91CrossRefPubMed Ozaki Y, Nomura S, Nagahama M et al (2000) Vitamin-D receptor genotype and renal disorder in Japanese patients with systemic lupus erythematosus. Nephron 85(1):86–91CrossRefPubMed
14.
go back to reference Huang CM, Wu MC, Wu JY et al (2002) Association of vitamin D receptor gene BsmI polymorphisms in Chinese patients with systemic lupus erythematosus. Lupus 11(1):31–34CrossRefPubMed Huang CM, Wu MC, Wu JY et al (2002) Association of vitamin D receptor gene BsmI polymorphisms in Chinese patients with systemic lupus erythematosus. Lupus 11(1):31–34CrossRefPubMed
15.
go back to reference Sakulpipatsin W, Verasertniyom O, Nantiruj K et al (2006) Vitamin D receptor gene BsmI polymorphisms in Thai patients with systemic lupus erythematosus. Arthritis Res Ther 8(2):R48CrossRefPubMedPubMedCentral Sakulpipatsin W, Verasertniyom O, Nantiruj K et al (2006) Vitamin D receptor gene BsmI polymorphisms in Thai patients with systemic lupus erythematosus. Arthritis Res Ther 8(2):R48CrossRefPubMedPubMedCentral
16.
go back to reference Abbasi M, Rezaieyazdi Z, Afshari JT et al (2010) Lack of association of vitamin D receptor gene BsmI polymorphisms in patients with systemic lupus erythematosus. Rheumatol Int 30(11):1537–1539CrossRefPubMed Abbasi M, Rezaieyazdi Z, Afshari JT et al (2010) Lack of association of vitamin D receptor gene BsmI polymorphisms in patients with systemic lupus erythematosus. Rheumatol Int 30(11):1537–1539CrossRefPubMed
17.
go back to reference Luo XY, Yang MH, Wu FX et al (2012) Vitamin D receptor gene BsmI polymorphism B allele, but not BB genotype, is associated with systemic lupus erythematosus in a Han Chinese population. Lupus 21(1):53–59CrossRefPubMed Luo XY, Yang MH, Wu FX et al (2012) Vitamin D receptor gene BsmI polymorphism B allele, but not BB genotype, is associated with systemic lupus erythematosus in a Han Chinese population. Lupus 21(1):53–59CrossRefPubMed
18.
go back to reference Monticielo OA, Brenol JC, Chies JA et al (2012) The role of BsmI and FokI vitamin D receptor gene polymorphisms and serum 25-hydroxyvitamin D in Brazilian patients with systemic lupus erythematosus. Lupus 21(1):43–52CrossRefPubMed Monticielo OA, Brenol JC, Chies JA et al (2012) The role of BsmI and FokI vitamin D receptor gene polymorphisms and serum 25-hydroxyvitamin D in Brazilian patients with systemic lupus erythematosus. Lupus 21(1):43–52CrossRefPubMed
19.
go back to reference Kaleta B, Bogaczewicz J, Robak E et al (2013) Vitamin D receptor gene BsmI polymorphism in polish patients with systemic lupus erythematosus. ISRN Endocrinol 2013:427818CrossRefPubMedPubMedCentral Kaleta B, Bogaczewicz J, Robak E et al (2013) Vitamin D receptor gene BsmI polymorphism in polish patients with systemic lupus erythematosus. ISRN Endocrinol 2013:427818CrossRefPubMedPubMedCentral
20.
go back to reference Mostowska A, Lianeri M, Wudarski M et al (2013) Vitamin D receptor gene BsmI, FokI, ApaI and TaqI polymorphisms and the risk of systemic lupus erythematosus. Mol Biol Rep 40(2):803–810CrossRefPubMedPubMedCentral Mostowska A, Lianeri M, Wudarski M et al (2013) Vitamin D receptor gene BsmI, FokI, ApaI and TaqI polymorphisms and the risk of systemic lupus erythematosus. Mol Biol Rep 40(2):803–810CrossRefPubMedPubMedCentral
21.
go back to reference Carvalho C, Marinho A, Leal B et al (2015) Association between vitamin D receptor (VDR) gene polymorphisms and systemic lupus erythematosus in Portuguese patients. Lupus 24(8):846–853CrossRefPubMed Carvalho C, Marinho A, Leal B et al (2015) Association between vitamin D receptor (VDR) gene polymorphisms and systemic lupus erythematosus in Portuguese patients. Lupus 24(8):846–853CrossRefPubMed
22.
go back to reference Holick MF (2004) Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr 80(6 Suppl):1678S–1688SPubMed Holick MF (2004) Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr 80(6 Suppl):1678S–1688SPubMed
23.
go back to reference Grant WB (2006) Epidemiology of disease risks in relation to vitamin D insufficiency. Prog Biophys Mol Biol 92(1):65–79CrossRefPubMed Grant WB (2006) Epidemiology of disease risks in relation to vitamin D insufficiency. Prog Biophys Mol Biol 92(1):65–79CrossRefPubMed
24.
go back to reference Lemire JM, Ince A, Takashima M (1992) 1,25-Dihydroxyvitamin D3 attenuates the expression of experimental murine lupus of MRL/l mice. Autoimmunity 12(2):143–148CrossRefPubMed Lemire JM, Ince A, Takashima M (1992) 1,25-Dihydroxyvitamin D3 attenuates the expression of experimental murine lupus of MRL/l mice. Autoimmunity 12(2):143–148CrossRefPubMed
25.
go back to reference Ritterhouse LL, Crowe SR, Niewold TB et al (2011) Vitamin D deficiency is associated with an increased autoimmune response in healthy individuals and in patients with systemic lupus erythematosus. Ann Rheum Dis 70(9):1569–1574CrossRefPubMedPubMedCentral Ritterhouse LL, Crowe SR, Niewold TB et al (2011) Vitamin D deficiency is associated with an increased autoimmune response in healthy individuals and in patients with systemic lupus erythematosus. Ann Rheum Dis 70(9):1569–1574CrossRefPubMedPubMedCentral
26.
go back to reference O’Regan S, Chesney RW, Hamstra A et al (1979) Reduced serum 1,25-(OH)2 vitamin D3 levels in prednisone-treated adolescents with systemic lupus erythematosus. Acta Paediatr Scand 68(1):109–111CrossRefPubMed O’Regan S, Chesney RW, Hamstra A et al (1979) Reduced serum 1,25-(OH)2 vitamin D3 levels in prednisone-treated adolescents with systemic lupus erythematosus. Acta Paediatr Scand 68(1):109–111CrossRefPubMed
27.
go back to reference Hamza RT, Awwad KS, Ali MK et al (2011) Reduced serum concentrations of 25-hydroxy vitamin D in Egyptian patients with systemic lupus erythematosus: relation to disease activity. Med Sci Monit 17(12):CR711–CR718CrossRefPubMedPubMedCentral Hamza RT, Awwad KS, Ali MK et al (2011) Reduced serum concentrations of 25-hydroxy vitamin D in Egyptian patients with systemic lupus erythematosus: relation to disease activity. Med Sci Monit 17(12):CR711–CR718CrossRefPubMedPubMedCentral
28.
go back to reference McGhie TK, DeCeulaer K, Walters CA et al (2014) Vitamin D levels in Jamaican patients with systemic lupus erythematosus. Lupus 23(10):1092–1096CrossRefPubMed McGhie TK, DeCeulaer K, Walters CA et al (2014) Vitamin D levels in Jamaican patients with systemic lupus erythematosus. Lupus 23(10):1092–1096CrossRefPubMed
29.
go back to reference Garf KE, Marzouk H, Farag Y et al (2015) Vitamin D status in Egyptian patients with juvenile-onset systemic lupus erythematosus. Rheumatol Int 35(9):1535–1540CrossRefPubMed Garf KE, Marzouk H, Farag Y et al (2015) Vitamin D status in Egyptian patients with juvenile-onset systemic lupus erythematosus. Rheumatol Int 35(9):1535–1540CrossRefPubMed
30.
go back to reference Yap KS, Northcott M, Hoi AB et al (2015) Association of low vitamin D with high disease activity in an Australian systemic lupus erythematosus cohort. Lupus Sci Med 2(1):e000064CrossRefPubMedPubMedCentral Yap KS, Northcott M, Hoi AB et al (2015) Association of low vitamin D with high disease activity in an Australian systemic lupus erythematosus cohort. Lupus Sci Med 2(1):e000064CrossRefPubMedPubMedCentral
31.
go back to reference Morrison NA, Qi JC, Tokita A et al (1994) Prediction of bone density from vitamin D receptor alleles. Nature 367(6460):284–287CrossRefPubMed Morrison NA, Qi JC, Tokita A et al (1994) Prediction of bone density from vitamin D receptor alleles. Nature 367(6460):284–287CrossRefPubMed
32.
go back to reference Alroy I, Towers TL, Freedman LP (1995) Transcriptional repression of the interleukin-2 gene by vitamin D3: direct inhibition of NFATp/AP-1 complex formation by a nuclear hormone receptor. Mol Cell Biol 15(10):5789–5799CrossRefPubMedPubMedCentral Alroy I, Towers TL, Freedman LP (1995) Transcriptional repression of the interleukin-2 gene by vitamin D3: direct inhibition of NFATp/AP-1 complex formation by a nuclear hormone receptor. Mol Cell Biol 15(10):5789–5799CrossRefPubMedPubMedCentral
33.
go back to reference Lemire JM, Adams JS, Kermani-Arab V et al (1985) 1,25-Dihydroxyvitamin D3 suppresses human T helper/inducer lymphocyte activity in vitro. J Immunol 134(5):3032–3035PubMed Lemire JM, Adams JS, Kermani-Arab V et al (1985) 1,25-Dihydroxyvitamin D3 suppresses human T helper/inducer lymphocyte activity in vitro. J Immunol 134(5):3032–3035PubMed
Metadata
Title
Impact of the polymorphism in vitamin D receptor gene BsmI and the risk of systemic lupus erythematosus: an updated meta-analysis
Authors
Weiping Hu
Guodong Niu
Yong Lin
Xiaoqing Chen
Ling Lin
Publication date
01-04-2016
Publisher
Springer London
Published in
Clinical Rheumatology / Issue 4/2016
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-015-3157-x

Other articles of this Issue 4/2016

Clinical Rheumatology 4/2016 Go to the issue

Review Article

Acute sacroiliitis

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.